Author: Steve Kopczak

• Breast Cancer Screening Utilization and Outcomes in Women with Neurofibromatosis Type 1.
• Yan K, Gao Y, Heller SL.
• Clin Breast Cancer. 2023 Feb 12:S1526-8209(23)00035-6. doi: 10.1016/j.clbc.2023.02.005. Epub ahead of print.

• Source abstract

• Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis.
• Allen I, Hassan H, Sofianopoulou E, Eccles D, Turnbull C, Tischkowitz M, Pharoah P, Antoniou AC.
• Breast Cancer Res. 2023 Feb 10;25(1):18. doi: 10.1186/s13058-023-01610-x.

• PMID: 36765408
• PubMed abstract

• Free Full Text

• Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study.
• Leblanc E, Narducci F, Ferron G, Mailliez A, Charvolin JY, El Hajj H, Guyon F, Fourchotte V, Lambaudie E, Crouzet A, Fouche Y, Gouy S, Collinet P, Caquant F, Pomel C, Golfier F, Vaini-Cowen V, Fournier I, Salzet M, Tresch E, Probst A, Lemaire AS, Le Deley MC, Hudry D.
• Cancers (Basel). 2023 Feb 10;15(4):1141. doi: 10.3390/cancers15041141.

• Free Full Text

Related:

•• Identifier: NCT01608074: Radical Fimbriectomy for Young BRCA Mutation Carriers (Fimbriectomy). (ClinicalTrials.gov . Accessed 2023 Feb 12.)

• Dr. Walden on the RNA Expression of Homologous Recombination Genes in CRC.
• Walden D.
• OncLive. OncLive TV. 2023 Feb 10.

• Conference report. Video
• Free video

• Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas.
• Würtemberger J, Ripperger T, Vokuhl C, Bauer S, Teichert-von Lüttichau I, Wardelmann E, Niemeyer C, Kratz CP, Schlegelberger B, Hettmer S.
• Eur J Med Genet. 2023 Feb 8:104718. doi: 10.1016/j.ejmg.2023.104718. Epub ahead of print.

• PMID: 36764384
• PubMed abstract
• Source abstract

• Review

• Coping Self-Efficacy and Its Relationship with Psychological Morbidity after Genetic Test Result Disclosure: Results from Cancer-Unaffected BRCA1/2 Mutation Carriers.
• Isselhard A, Lautz Z, Töpper M, Rhiem K, Schmutzler R, Vitinius F, Fischer H, Berger-Höger B, Steckelberg A, Beifus K, Köberlein-Neu J, Stock S.
• Int J Environ Res Public Health. 2023 Jan 17;20(3):1684. doi: 10.3390/ijerph20031684.

• PMID: 36767056
• PubMed abstract

• Free Full Text

• Implementing digital systems to facilitate genetic testing for hereditary cancer syndromes: An observational study of four clinical workflows.
• Wang C, Lu H, Bowen DJ, Xuan Z.
• Genet Med. 2023 Feb 10:S1098-3600(23)00815-8. doi: 10.1016/j.gim.2023.100802. Epub ahead of print.

• Source abstract

• Breast Cancer Risk Assessment Tools for Stratifying Women into Risk Groups: A Systematic Review.
• Velentzis LS, Freeman V, Campbell D, Hughes S, Luo Q, Steinberg J, Egger S, Mann GB, Nickson C.
• Cancers (Basel). 2023 Feb 9;15(4):1124. doi: 10.3390/cancers15041124.

• Review
• Free Full Text

• Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.
• Musacchio L, Boccia S, Marchetti C, Minucci A, Camarda F, Cassani C, Ventriglia J, Salutari V, Ghizzoni V, Giudice E, Perri MT, Carbone MV, Ricci C, Pignata S, Fagotti A, Scambia G, Lorusso D.
• Int J Gynecol Cancer. 2023 Feb 9:ijgc-2022-003903. doi: 10.1136/ijgc-2022-003903. Epub ahead of print.

• PMID: 36759000
• PubMed abstract
• Source abstract

• Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601.
• Perez-Fidalgo JA, Guerra E, García Y, Iglesias M, Hernández-Sosa M, Estevez-García P, Manso Sánchez L, Santaballa A, Oaknin A, Redondo A, Rubio MJ, González-Martín A.
• Int J Gynecol Cancer. 2023 Feb 9:ijgc-2022-004028. doi: 10.1136/ijgc-2022-004028. Epub ahead of print.

• PMID: 36759001
• PubMed abstract
• Source abstract

• Counselling of path_BRCA carriers who are considering risk-reducing oophorectomy.
• Manley K, Ryan N, Jenner A, Newton C, Hillard T.
• Post Reprod Health. 2023 Feb 9:20533691231156640. doi: 10.1177/20533691231156640. Epub ahead of print.

• PMID: 36757900
• PubMed abstract
• Source abstract

• Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
• Zwimpfer TA, Schwab FD, Steffens D, Kaul F, Schmidt N, Geiger J, Geissler F, Heinzelmann-Schwarz V, Weber WP, Kurzeder C.
• World J Surg Oncol. 2023 Feb 9;21(1):40. doi: 10.1186/s12957-023-02918-w.

• PMID: 36755294
• PubMed abstract

• Case report
• Free PMC article
• Free Full Text

• Radiotherapy, PARP Inhibition, and Immune-Checkpoint Blockade: A Triad to Overcome the Double-Edged Effects of Each Single Player.
• Rosado MM, Pioli C.
• Cancers (Basel). 2023 Feb 8;15(4):1093. doi: 10.3390/cancers15041093.

• Review
• Free Full Text

• 2022 : nouvelles pratiques thérapeutiques en oncologie mammaire [2022: New therapeutic practices in breast oncology].
• Deluche E, Verret B.
• Bull Cancer. 2023 Feb 7:S0007-4551(23)00036-X. French. doi: 10.1016/j.bulcan.2023.01.002. Epub ahead of print.

• PMID: 36759216
• PubMed abstract
• Source abstract

• Review. [Article in French]

• Study on TFF1 and PALB2 gene variants associated with gastric carcinoma risk in the Chinese Han population.
• Zou W, Zhang Q, Sun R, Li X, He S.
• Cancer Epidemiol. 2023 Feb 7;83:102333. doi: 10.1016/j.canep.2023.102333. Epub ahead of print.

• PMID: 36758349
• PubMed abstract
• Source abstract